Vimarsana
Biggest News Aggregation in the World

Page 19 - Pharma Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Group Today - Breaking & Trending Today

Spasticity Treatment Market size to grow by USD 1.11 billion from 2021 to 2026, Driven by the growing incidence of chronic diseases and health conditions - Vimarsana News

Spasticity Treatment Market size to grow by USD 1.11 billion from 2021 to 2026, Driven by the growing incidence of chronic diseases and health conditions

/PRNewswire/ -- The spasticity treatment market size is forecast to increase by USD 1.11 billion from 2021 to 2026, at a CAGR of 4.17%, according to the recent...

Hedgehog pathway inhibitors market size to grow by USD 385.52 million from 2021 to 2026; Bristol Myers Squibb Co., Infinity Pharmaceuticals Inc., among others, identified as key vendors - Vimarsana News

Hedgehog pathway inhibitors market size to grow by USD 385.52 million from 2021 to 2026; Bristol Myers Squibb Co., Infinity Pharmaceuticals Inc., among others, identified as key vendors

/PRNewswire/ -- The hedgehog pathway inhibitors market size is forecasted to increase by USD 385.52 million from 2021 to 2026, at a CAGR of 13%, according to...

APONTIS PHARMA: New development partnership with Midas Pharma – Expansion of Single Pill portfolio with EU-wide property rights opens up additional revenue potential - Vimarsana News

APONTIS PHARMA: New development partnership with Midas Pharma – Expansion of Single Pill portfolio with EU-wide property rights opens up additional revenue potential

EQS-News: APONTIS PHARMA AG / Key word: Product Launch APONTIS PHARMA: New development partnership with Midas Pharma – Expansion of Single Pill portfolio with EU-wide property... | April 12, 2023

APONTIS PHARMA: New development partnership with Midas Pharma – Expansion of Single Pill portfolio w - Vimarsana News

APONTIS PHARMA: New development partnership with Midas Pharma – Expansion of Single Pill portfolio w

EQS-News: APONTIS PHARMA AG / Key word(s): Product LaunchAPONTIS PHARMA: New development partnership with Midas Pharma – Expansion of Single Pill portfolio with EU-wide property rights opens up additional revenue potential 12.04.2023 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announceme...

Covis Pharma to Take Preterm Birth Drug Makena Off the Market - Stock market news - Vimarsana News

Covis Pharma to Take Preterm Birth Drug Makena Off the Market - Stock market news

By Will Feuer Covis Pharma Group said it would stop selling Makena, the only drug that was on the market to help prevent preterm births, after the U.S. Food and Drug Administration said it withdrew its approval for the drug. The FDA on Thursda... | 09:06am